Wish I had read this information before I brought in at .77 last week. I hope im wrong as I cant see were Moxduo has a safety advantage over the two individual doses. That seems to be the sticking point. We just jiggle around the results and still it fails to be a safety advantage. If It were me I would say no as it still doesn't clearly satisfy the dual drug law, compared to individual doses. It may be more convenient but they cant really prove any synergies.
Shit
Fingers crossed
Graeme
- Forums
- ASX - By Stock
- QRX
- palms are sweaty
palms are sweaty, page-22
Featured News
Add QRX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online